Skip to content
    Reviews

    Exercise as anticancer medicine? Evidence, mechanisms and implementation in oncology

    Schmidinger et alCancer treatment reviews

    Exercise as anticancer medicine? Evidence, mechanisms and implementation in oncology
    Research over the past two decades has repositioned exercise from a general lifestyle recommendation into an evaluated anticancer intervention. Pooled analyses comprising more than 1.4 million participants link regular physical activity with a lower incidence of at least 13 tumour types. Furthermore, prospective cohort data indicate that cancer-specific mortality is 24% to 31% lower among the most active patients with breast, colorectal, prostate, and lung cancer, although these observational estimates rely on self-reported activity.
    Randomised trial evidence remains mixed across malignancies. A 2025 phase III trial in stage III colon cancer provided the first randomised evidence that a structured exercise and behaviour-change programme improves disease-free survival and overall survival following adjuvant chemotherapy; however, a subsequent randomised trial in ovarian cancer did not show a progression-free survival benefit.
    Proposed biological mechanisms include alterations in insulin and growth-factor signalling, myokine secretion, immune mobilisation, reductions in chronic inflammation, and gut microbiome remodelling, supported by evidence spanning cell culture to human trials that are rarely distinguished by level. Despite the available data, routine integration into oncology care faces persistent structural, educational, and economic barriers.

    Key Takeaways

    • Prospective cohort data report cancer-specific mortality 24% to 31% lower among the most active patients with breast, colorectal, prostate, and lung cancer, alongside pooled analyses of more than 1.4 million participants linking regular physical activity to lower incidence across at least 13 tumour types.
    • A phase III trial in stage III colon cancer provided the first randomised evidence that a structured exercise and behaviour-change programme improves disease-free and overall survival after adjuvant chemotherapy, whereas a randomised trial in ovarian cancer did not show a progression-free survival benefit.
    Read the original sourceCancer treatment reviews